文献速递腹部介入US

原发与继发性人肝肿瘤的超声衰减系数评估及其对高强度聚焦超声治疗的潜在影响

Evaluation of Ultrasonic Attenuation in Primary and Secondary Human Liver Tumors and Its Potential Effect on High-Intensity Focused Ultrasound Treatment.
PubMed 文献 · Ultrasound Med Biol · 2021-04-22

研究对8例原发性与13例继发性人肝肿瘤新鲜手术标本测量超声衰减系数,原发与继发肿瘤平均分别为0.10±0.03与0.20±0.04 Np/cm/MHz,瘤周肝组织分别为0.16±0.07与0.07±0.02 Np/cm/MHz。数值模拟显示相同HIFU参数下继发肿瘤消融灶尺寸约为原发肿瘤的两倍,提示HIFU治疗参数需根据病变肝组织声学特性设置。

要点

  • 原发与继发性肝肿瘤的超声衰减系数存在明显差异,继发肿瘤衰减更高。
  • 瘤周肝组织的衰减特性在原发与继发肿瘤间呈相反趋势,影响HIFU能量沉积。
  • 相同HIFU参数下继发肿瘤消融灶约为原发肿瘤两倍,提示需个体化设置参数。

核心结论

  • 原发与继发性肝肿瘤及其瘤周肝组织的超声衰减系数不同,可导致相同HIFU暴露参数下产生完全不同的消融模式。
  • 继发性肝肿瘤的平均衰减系数高于原发性肿瘤,而原发瘤周肝组织衰减高于继发瘤周肝组织。
  • HIFU治疗参数应根据病变肝组织的声学特性进行适当设置。

研究设计与样本

  • 研究类型为离体人肝肿瘤标本的声学参数测量研究,标本经肝切除术获取。
  • 样本包括原发性肝肿瘤8例和继发性肝肿瘤13例新鲜标本。
  • 测量指标为超声衰减系数,并基于测得值进行数值模拟评估HIFU消融模式。

诊断标准与关键数值

  • 原发性肝肿瘤平均衰减系数为0.10±0.03 Np/cm/MHz,继发性肝肿瘤为0.20±0.04 Np/cm/MHz。
  • 原发肿瘤周围肝组织平均衰减系数为0.16±0.07 Np/cm/MHz,继发肿瘤周围肝组织为0.07±0.02 Np/cm/MHz。
  • 数值模拟中相同暴露参数下继发性肝肿瘤的典型HIFU消融灶尺寸约为原发性肿瘤的两倍。

临床应用与阅片要点

  • 在HIFU治疗规划中应考虑原发与继发性肝肿瘤及其瘤周肝组织的声学衰减差异,避免统一参数。
  • 继发性肝肿瘤衰减较高,相同参数下可能产生更大消融灶,需注意邻近组织损伤风险。
  • 原发肿瘤瘤周肝组织衰减较高,可能影响能量沉积与消融范围,阅片评估时应关注瘤周肝背景。

局限性

  • 研究为离体标本测量,样本量有限(原发8例、继发13例),结果需在体研究验证。
  • 数值模拟基于理想化模型,未完全反映在体血流灌注与呼吸运动等影响因素。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Primary and secondary liver tumors are completely different diseases but are usually treated similarly using high-intensity focused ultrasound (HIFU). However, the acoustic parameters of these tissues are not well documented. In this study, attenuation coefficients were evaluated in fresh primary (N = 8) and secondary (N = 13) human liver tumor samples recovered by hepatectomy. The average attenuation coefficients of the primary and secondary liver tumors were 0.10 ± 0.03 and 0.20 ± 0.04 Np/cm/MHz, respectively. The average attenuation coefficients of the liver tissue surrounding the primary and secondary tumors were 0.16 ± 0.07 and 0.07 ± 0.02 Np/cm/MHz, respectively. Numerical simulations performed using these values revealed that completely different HIFU ablation patterns were created in primary and secondary liver tumors using the same exposure parameters. The dimensions of a typical HIFU lesion were two times larger in secondary liver tumors than in primary tumors. HIFU treatment parameters should be set properly according to the acoustic properties of the diseased liver tissue.

来源:Ultrasound Med Biol,查看原文。版权归原作者所有。

引用

  1. Barrere V, Sanchez M, Cambronero S, et al. Evaluation of Ultrasonic Attenuation in Primary and Secondary Human Liver Tumors and Its Potential Effect on High-Intensity Focused Ultrasound Treatment. Ultrasound Med Biol. 2021. PMID: 33895037. doi:10.1016/j.ultrasmedbio.2021.03.014

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。